Pharmaceutical companies in the United States by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 27 pharmaceutical companies in the United States ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 20 Nov 2026, 02:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 27
- First
- Royalty Pharma65.6%
- Median
- 5.88%
- Combined market value
- SEK 38.1T
- Countries
- 1
- Not ranked
- 17no operating margin on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | SEK 397.1B | SEK 690.69 | 1.38% down | 79% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | SEK 49.7B | SEK 594.87 | 3.16% down | 21% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | SEK 242.9B | SEK 5,702.34 | 3.16% down | 22% up | ||
| 4 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | SEK 1.35T | SEK 5,310.29 | 2.94% down | 27% up | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | SEK 974.2B | SEK 9,417.28 | 2.35% down | 28% up | ||
| 6 | AbbVieABBV · Health Care | 24.6% | SEK 5.11T | SEK 2,891.87 | 0.86% down | 25% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | 20.0% | SEK 100B | SEK 661.72 | 1.88% down | 117% up | ||
| 8 | Abbott LaboratoriesABT · Health Care | 18.2% | SEK 1.83T | SEK 1,059.39 | 0.58% down | 16% down | ||
| 9 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | SEK 58.5B | SEK 2,926.54 | 3.94% down | 50% up | ||
| 10 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | SEK 201.9B | SEK 1,507.64 | 1.06% down | 66% down | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | SEK 76B | SEK 218.16 | 2.24% down | 90% up | ||
| 12 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | SEK 121.3B | SEK 626.43 | 0.02% down | 17% up | ||
| 13 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | SEK 62.9B | SEK 445.19 | 1.25% up | 13% up | ||
| 14 | Corcept TherapeuticsCORT · Health Care | 5.88% | SEK 72.5B | SEK 662.74 | 4.15% down | 10% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | SEK 63.6B | SEK 974.12 | 3.27% up | 34% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | -12.8% | SEK 47.3B | SEK 492.62 | 3.86% down | 45% up | ||
| 17 | Legend BiotechLEGN · Health Care | -13.3% | SEK 31.9B | SEK 164.21 | 0.92% down | 41% down | ||
| 18 | ViatrisVTRS · Health Care | -18.6% | SEK 232.5B | SEK 202.76 | 1.97% down | 99% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -26.1% | SEK 72.8B | SEK 1,383.82 | 1.25% up | 6% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | SEK 94B | SEK 4,046.41 | 0.34% down | 27% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | SEK 46.2B | SEK 277.62 | 0.62% down | 63% down | ||
| 22 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | SEK 82.6B | SEK 1,191.26 | 1.88% down | 18% up | ||
| 23 | BridgeBio PharmaBBIO · Health Care | -104% | SEK 155.3B | SEK 797.37 | 0.22% up | 21% up | ||
| 24 | InsmedINSM · Health Care | -206% | SEK 323.2B | SEK 1,473.37 | 20.58% up | 40% down | ||
| 25 | Protagonist TherapeuticsPTGX · Health Care | -344% | SEK 82.6B | SEK 1,264.90 | 2.47% down | 51% up | ||
| 26 | CytokineticsCYTK · Health Care | -695% | SEK 73.1B | SEK 524.85 | 0.27% up | 19% down | ||
| 27 | Dianthus TherapeuticsDNTH · Health Care | -8739% | SEK 48.7B | SEK 865.19 | 1.01% up | 108% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1991 SEK). 17 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 27 pharmaceutical companies in the United States ranked by operating margin as of 20 Nov 2026, 02:03 UTC.
How many pharmaceutical companies in the United States are in this ranking?
27 are ranked by operating margin. 17 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 27 pharmaceutical companies in the United States ranked by operating margin have a combined market value of SEK 38.1T as of 20 Nov 2026, 02:03 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by operating margin”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.